In Re Kauffman Mutual Fund Actions

337 F. Supp. 1337, 1972 U.S. Dist. LEXIS 15449, 1972 Trade Cas. (CCH) 73,815
CourtUnited States Judicial Panel on Multidistrict Litigation
DecidedJanuary 21, 1972
Docket78
StatusPublished
Cited by36 cases

This text of 337 F. Supp. 1337 (In Re Kauffman Mutual Fund Actions) is published on Counsel Stack Legal Research, covering United States Judicial Panel on Multidistrict Litigation primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
In Re Kauffman Mutual Fund Actions, 337 F. Supp. 1337, 1972 U.S. Dist. LEXIS 15449, 1972 Trade Cas. (CCH) 73,815 (jpml 1972).

Opinion

OPINION AND ORDER

PER CURIAM.

In 1968 Joseph B. Kauffman filed an action in the United States District Court for the District of New Jersey against sixty-five (65) mutual funds, thirty-eight (38) investment advisers managing those funds, thirty-seven (37) directors affiliated with both the funds and the investment advisers, and the Investment Company Institute, the trade association representative for the mutual fund industry. The complaint consisted of three counts. Count 1 was brought for violations of Sections 1 and 2 of the Sherman Act, 15 U.S.C. §§ 1, 2, and alleged a conspiracy among the defendants to fix the schedule of management fees charged the funds and to refrain from competing for the business of externally-managed mutual funds or of investment advisers. Count 2 alleged violation of the Investment Company Act, of 1940, 15 U.S.C. §§ 80a-l to -52, in connection with the brokerage practices of “give-ups” and “reciprocals.” 1 Count 3 was brought under the Securities Exchange Act of 1934, 15 U.S.C. §§ 78a-78hh. The Investment Advisers Act of 1940, 15 U.S.C. §§ 80b-l to -21, and the Investment Company Act and alleged that the defendants had issued certain proxy statements and other announcements and reports which misstated and/or failed to disclose material facts concerning the alleged antitrust and Investment Company Act violations.

The district court allowed Kauffman to represent a class composed of all shareholders of the defendant funds, as well as representing all the funds derivatively. On appeal, however, Kauffman’s standing was limited to derivative claims on behalf of the four funds in which he was a shareholder. Kauffman v. Dreyfus Fund, Inc., 434 F.2d 727 (3d Cir. 1970). Kauffman now asserts the antitrust allegations of Count 1 on behalf of those four funds against the other defendants and asserts the securities law counts against those four funds.

After the decision on appeal, the action was remanded to the District of New Jersey where the great majority of defendants moved for dismissal on venue grounds. It appears that Kauffman agreed not to contest these motions and consented to the transfer of the action, under 28 U.S.C. § 1406(a), to the district courts previously designated by the defendants as ones wherein the action could have been brought. The district court severed the alleged securities law violations of Counts 2 and 3 from the antitrust claims of Count 1 and treated them separately for purposes of transfer. The result was the transfer of the antitrust action to nine additional districts and the separate transfer of the securities law action to two districts (in which antitrust actions were also pending).

After the transfers became effective Kauffman moved the Panel for transfer of the ten antitrust and two securities law actions to the Southern District of *1339 New York under 28 U.S.C. § 1407. He asserts that the identical allegations of the ten antitrust complaints raise common questions of fact concerning the existence of the alleged conspiracy among the defendants, including the Investment Company Institute, and the fraudulent concealment of that conspiracy. The securities law actions are said to be a necesssary part of the litigation because they involve common defendants and rest, in part, on proxy law violations concerning failure to disclose the alleged antitrust violations.

All defendants responding to the motion have opposed transfer, urging two basic contentions. First they deny the existence of sufficient questions of fact common to both the antitrust and securities law actions to justify coordinated pre-trial proceedings. Second, they urge that despite the obvious common questions of fact in the antitrust actions Kauffman is precluded from seeking their transfer under Section 1407 by his prior conduct. Although we find the defendants’ argument against inclusion of the securities law actions compelling, we deem it necessary, absent a voluntary plan for coordination of discovery, to transfer the antitrust actions for coordinated or consolidated pretrial proceedings and have concluded that the District of Massachusetts is the most appropriate transferee district.

The defendants have convincingly argued that, after the appellate decision limiting Kauffman’s standing, the two securities law actions involve only the four mutual funds in which Kauffman holds stock. Obvious support for this contention is provided by the fact that the district court severed the antitrust counts from the securities law counts in its transfer under Section 1406(a). The fact that the defendants in these two actions are also among the parties in the antitrust counts and that one of the alleged securities law violations was their failure to disclose the alleged antitrust violations is not sufficient common factual background to tie the otherwise quite different groups of cases together. In re Scotch Whiskey Antitrust Litigation, 299 F.Supp. 543 (J.P.M.L.1969).

The defendants’ opposition to transfer of the antitrust cases, however, is unconvincing. They concede the existence of common questions of fact and apparently acknowledge the potential for duplication of effort and judicial inconsistency. At the hearing on this matter, it was suggested to the defendants that voluntary coordination of discovery by agreement of the defendants might be a workable alternative to transfer by the Panel and the defendants were given an opportunity to work out such a plan and submit it to the Panel. The defendants have not used the opportunity and apparently choose to rely on the arguments in opposition to transfer advanced in their briefs and at the hearing.

The defendants advance several arguments against transfer of the antitrust cases to a single district. They say that it would be unfair to order transfer of all defendants to one district for pretrial proceedings when defendants have expended considerable time and effort in defeating Kauffman’s attempt to sue all defendants in one district. In essence, their argument is that Kauffman should not be able to secure from the Panel, under 28 U.S.C. § 1407, what the venue provisions of federal law otherwise prohibit. However, the Panel’s discretion under Section 1407 is not limited by venue considerations and the fact that defendants may not all be amenable to suit in the same jurisdiction does not prevent their transfer to a single district for pretrial proceedings where the prerequisites of Section 1407 are otherwise satisfied.

Defendants also argue that Section 1407 should not be used to further litigation of questionable merit. Kauffman’s complaint must be presumed meritorious at this stage of the litigation, however.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Wright v. AT&T
D. Montana, 2025
Hart v. T-Mobile U.S. Inc.
N.D. California, 2023
Perry v. Evenflo Company, Inc.
D. Massachusetts, 2020
Perry v. Evenflo Company, Inc.
E.D. California, 2020
In re Allura Fiber Cement Siding Prods. Liab. Litig.
366 F. Supp. 3d 1365 (Judicial Panel on Multidistrict Litigation, 2019)
In re Patriot Nat'l, Inc., Sec. Litig.
349 F. Supp. 3d 1379 (Judicial Panel on Multidistrict Litigation, 2018)
In re Uber Techs., Inc., Data Sec. Breach Litig.
304 F. Supp. 3d 1351 (Judicial Panel on Multidistrict Litigation, 2018)
In re Air Crash over the Southern Indian Ocean
190 F. Supp. 3d 1358 (Judicial Panel on Multidistrict Litigation, 2016)
In re Fluoroquinolone Products Liability Litigation
122 F. Supp. 3d 1378 (Judicial Panel on Multidistrict Litigation, 2015)
In re Xarelto (Rivaroxaban) Products Liability Litigation
65 F. Supp. 3d 1402 (Judicial Panel on Multidistrict Litigation, 2014)
In re Fresh Dairy Products Antitrust Litigation (No. II)
959 F. Supp. 2d 1361 (Judicial Panel on Multidistrict Litigation, 2013)
In re Anheuser-Busch Beer Labeling Marketing & Sales Practices Litigation
949 F. Supp. 2d 1371 (Judicial Panel on Multidistrict Litigation, 2013)
In re Biomet M2a Magnum Hip Implant Products Liability Litigation
896 F. Supp. 2d 1339 (Judicial Panel on Multidistrict Litigation, 2012)
In re Maxim Integrated Products, Inc.
867 F. Supp. 2d 1333 (Judicial Panel on Multidistrict Litigation, 2012)
In re Wright Medical Technology, Inc.
844 F. Supp. 2d 1371 (Judicial Panel on Multidistrict Litigation, 2012)
In Re New Mexico Natural Gas Antitrust Litigation
482 F. Supp. 333 (Judicial Panel on Multidistrict Litigation, 1979)

Cite This Page — Counsel Stack

Bluebook (online)
337 F. Supp. 1337, 1972 U.S. Dist. LEXIS 15449, 1972 Trade Cas. (CCH) 73,815, Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-kauffman-mutual-fund-actions-jpml-1972.